Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30,680Revenue $M12,167Net Margin (%)16.1Z-Score2.9
Enterprise Value $M34,074EPS $3.8Operating Margin %20.4F-Score4
P/E(ttm))16.6Cash Flow Per Share $5.3Pre-tax Margin (%)19.0Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %5.4Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %9.2Current Ratio2.2Lower Leverage y-yN
Price/Cash Flow11.0y-y EBITDA Growth Rate %2.1ROA % (ttm)8.6Higher Current Ratio y-yN
Dividend Yield %1.5Insider Buy (3m)1ROE % (ttm)18.0Less Shares Outstanding y-yN
Payout Ratio %26.1Shares Outstanding M472ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with COV

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVLeon Cooperman 2013-03-31 Buy 0.93%$57.74 - $67.84
($62.91)
$ 65.174%New holding, 887300 sh.887,300
COVJean-Marie Eveillard 2013-03-31 Reduce-0.06%$57.74 - $67.84
($62.91)
$ 65.174%Reduce -30.95%700,891
COVRay Dalio 2013-03-31 Reduce-0.01%$57.74 - $67.84
($62.91)
$ 65.174%Reduce -22.49%60,996
COVRay Dalio 2012-12-31 Buy 0.05%$53.36 - $60.44
($57.11)
$ 65.1714%New holding, 78696 sh.78,696
COVJean-Marie Eveillard 2012-12-31 Reduce-0.06%$53.36 - $60.44
($57.11)
$ 65.1714%Reduce -21.14%1,014,988
COVJohn Paulson 2012-09-30 Sold Out -0.8%$50.6 - $59.77
($55.8)
$ 65.1717%Sold Out0
COVRay Dalio 2012-09-30 Sold Out -0.02%$50.6 - $59.77
($55.8)
$ 65.1717%Sold Out0
COVJean-Marie Eveillard 2012-06-30 Add0.08%$50.45 - $55.58
($53.41)
$ 65.1722%Add 44.58%1,297,817
COVDavid Dreman 2012-06-30 Sold Out -0.07%$50.45 - $55.58
($53.41)
$ 65.1722%Sold Out0
COVRay Dalio 2012-06-30 Reduce-0.02%$50.45 - $55.58
($53.41)
$ 65.1722%Reduce -45.17%22,700
COVDodge & Cox 2012-06-30 Reduce-0.02%$50.45 - $55.58
($53.41)
$ 65.1722%Reduce -59.14%152,928
COVJohn Paulson 2012-03-31 Buy 0.66%$45 - $54.72
($47.31)
$ 65.1738%New holding, 1800000 sh.1,800,000
COVJean-Marie Eveillard 2012-03-31 Add0.2%$45 - $54.72
($47.31)
$ 65.1738%Add 59743.7%897,655
COVMario Gabelli 2012-03-31 Add0.07%$45 - $54.72
($47.31)
$ 65.1738%Add 46.14%525,302
COVJohn Keeley 2012-03-31 Add0.02%$45 - $54.72
($47.31)
$ 65.1738%Add 30.33%81,910
COVJohn Hussman 2012-03-31 Sold Out -0.36%$45 - $54.72
($47.31)
$ 65.1738%Sold Out0
COVJohn Hussman 2011-12-31 Buy 0.36%$42.16 - $48.25
($45.07)
$ 65.1745%New holding, 500000 sh.500,000
COVDonald Yacktman 2011-12-31 Add0.11%$42.16 - $48.25
($45.07)
$ 65.1745%Add 21.7%1,682,375
COVVanguard Health Care Fund 2011-12-31 Add0.05%$42.16 - $48.25
($45.07)
$ 65.1745%Add 10.26%2,150,000
COVJohn Paulson 2011-12-31 Sold Out -0.43%$42.16 - $48.25
($45.07)
$ 65.1745%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
COV Leon Cooperman 2013-03-31887,3000.190.93New Buy
COV Vanguard Health Care Fund 2013-03-312,397,6000.510.64+14.17%
COV Donald Yacktman 2013-03-311,801,0750.380.63+7.27%
COV Mario Gabelli 2013-03-31553,4340.120.24+6.46%
COV John Keeley 2013-03-3181,0600.020.11+3.18%
COV Ronald Muhlenkamp 2013-03-31374,5400.085.2+0.78%
COV Yacktman Fund 2013-03-31850,0000.180.68
COV Yacktman Focused Fund 2013-03-31800,0000.170.74
COV Dodge & Cox 2013-03-31115,1170.020.01-2.43%
COV Ray Dalio 2013-03-3160,9960.010.04-22.49%
COV Jean-Marie Eveillard 2013-03-31700,8910.150.16-30.95%
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lannum Coleman N IIIVice President 2009-06-01Buy780$36.1680.34view
Lannum Coleman N IIIVice President 2009-05-18Buy460$35.4983.74view
Lannum Coleman N IIIVice President 2009-05-12Buy1,006$34.4189.51view
REILLEY DENNIS HDirector 2008-08-07Buy19,500$51.426.87view
Masterson John HSVP and General Counsel 2008-05-06Buy35$43.350.6view

Press Releases about COV:

Quarterly/Annual Reports about COV:

News about COV:

Articles On GuruFocus.com
My 4 Favorites from the 20 Most Recommended Dividend Stocks at All-Time Highs Jan 19 2013 
The 3 Most-Recommended Healthcare Stocks Jan 02 2013 
Paulson Says Bet Against Europe to Blame for Down Year, Slashed EU Holdings in Q3 Dec 06 2012 
Donald Yacktman Finds Two Undervalued Companies in His Most Bought, In-Favor Sector of Q3 Dec 04 2012 
GuruFocus.com Interview with Steve Romick, Portfolio Manager of FPA Crescent Oct 09 2012 
The Best Stocks With Dividend Growth From Last Week (September 24 – September 30, 2012) Sep 30 2012 
12 Dividend Challengers With Huge Potential To Become A Dividend Hero Sep 15 2012 
16 Best Dividend Paying Healthcare Stocks Sep 03 2012 
Q&A with Investor Steven Romick of FPA Funds Aug 28 2012 
Steven Romick's Top Stock Picks Jun 21 2012 

More From Our Partners
Covidien's ENB Adopted by ACCP - Analyst Blog May 23 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK